Literature DB >> 17699418

Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schönlein-Henoch purpura nephritis.

Masanori Hara1, Toshio Yanagihara, Itaru Kihara.   

Abstract

Recent studies have revealed that podocytopenia leads to glomerular scarring and that the loss of podocytes into the urine may be a cause of podocytopenia. The purpose of this study was to examine whether serial examinations of urinary podocytes (u-podo) could be a useful predictor of disease progression in children with glomerulonephritis. Urine samples and renal biopsy specimens from 20 patients (10 males and 10 females; mean age 11.8 yr; range 4 to 24 yr) with IgA nephropathy (n = 17) and Henoch-Schönlein purpura nephritis (n = 3) were analyzed. Forty-four renal biopsies were performed on 20 patients. Proteinuria (g/d per 1.73 m2), hematuria (score), and u-podo (cells/ml) were examined twice a month in 24 intervals between two biopsies (mean 16.7 mo; range 4 to 58 mo) and average and cumulative values were determined for the intervals. Renal histologic changes were scored on the basis of acute intracapillary, acute extracapillary, acute tubulointerstitial, chronic intracapillary, chronic extracapillary, and chronic tubulointerstitial lesions, as well as glomerulosclerosis. It was found that hematuria, proteinuria, u-podo, and acute lesion scores decreased during the intervals examined, whereas chronic lesion scores increased. Changes in acute histology scores correlated well with hematuria, proteinuria, and u-podo excretion, whereas chronic histology scores and glomerulosclerosis both correlated well with cumulative u-podo excretion. Patients with severe histologic progression of disease also had persistent u-podo excretion. These findings provide additional data to support a potential causative role for prolonged urinary loss of podocytes in disease progression in children with IgA nephropathy and Henoch-Schönlein purpura nephritis.

Entities:  

Mesh:

Year:  2007        PMID: 17699418     DOI: 10.2215/CJN.01470506

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  47 in total

1.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

2.  Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury.

Authors:  Alison L Kent; Linda Brown; Margaret Broom; Amy Broomfield; Jane E Dahlstrom
Journal:  Pediatr Nephrol       Date:  2012-03-14       Impact factor: 3.714

3.  Urinary podocyte mRNA is a potent biomarker of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

Authors:  Akihiro Minakawa; Akihiro Fukuda; Masao Kikuchi; Yuji Sato; Yuichiro Sato; Kazuo Kitamura; Shouichi Fujimoto
Journal:  Clin Exp Nephrol       Date:  2019-11-25       Impact factor: 2.801

4.  Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.

Authors:  Chayanut Suwanpen; Phonethipsavanh Nouanthong; Veeravich Jaruvongvanich; Krit Pongpirul; Wannarat Amornnimit Pongpirul; Asada Leelahavanichkul; Talerngsak Kanjanabuch
Journal:  J Nephrol       Date:  2015-04-24       Impact factor: 3.902

Review 5.  Mechanical challenges to the glomerulus and podocyte loss: evolution of a paradigm.

Authors:  Kevin V Lemley
Journal:  Pflugers Arch       Date:  2017-06-22       Impact factor: 3.657

Review 6.  The role of the podocyte in albumin filtration.

Authors:  Paul Thomas Brinkkoetter; Christina Ising; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

7.  Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.

Authors:  Patrícia Garcia Rodrigues; Rafael Nazário Bringhenti; Jonathan Frapporti do Nascimento; Gabriel Joelsons; Mariane dos Santos; Sane Pereira; Francisco Veríssimo Veronese
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

8.  Urinary and glomerular podocytes in patients with chronic kidney diseases.

Authors:  Kikuno Hanamura; Akihiro Tojo; Toshiro Fujita
Journal:  Clin Exp Nephrol       Date:  2013-05-15       Impact factor: 2.801

9.  Urine podocyte mRNAs mark progression of renal disease.

Authors:  Yuji Sato; Bryan L Wharram; Sang Koo Lee; Larysa Wickman; Meera Goyal; Madhusudan Venkatareddy; Jai Won Chang; Jocelyn E Wiggins; Chrysta Lienczewski; Matthias Kretzler; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

Review 10.  Progression of glomerular and tubular disease in pediatrics.

Authors:  Robert P Woroniecki; H William Schnaper
Journal:  Semin Nephrol       Date:  2009-07       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.